Mood Disorders Archives - Page 2 of 3

Postpartum depression declining but still relevant

Gaps Identified in Postpartum Depression Screening

By

August 7, 2020

Researchers explored provider screening practices in primary care, women’s health, and well-child clinics to determine if barriers exist in meeting postpartum depression screening guidelines.

An increased risk for the development of psychiatric disorders such as schizophrenia and social anxiety disorder has been found with the use of cannabis; depression to a lesser extent. Individuals who are heavy cannabis users are more likely to report suicidal thoughts than non-users. For patients with bipolar disorder, near-daily cannabis use seemed to increase symptoms of the disorder. However, for patients with schizophrenia or other psychoses, a history of cannabis use has been associated with better performance on learning and memory tasks.

Neurobehavioral Disorders

Sublingual Dexmedetomidine Promising for Acute Agitation With Schizophrenia, Bipolar Disorder

By

Brian Park, PharmD

July 23, 2020

Dexmedetomidine is currently available as a solution for intravenous infusion for use in clinical anesthesia and sedation in an intensive care setting.

Sad woman sitting on the floor near her bed

Sleep Disorders

Common Bedfellows: Sleep Disturbances and Psychiatric Disorders

By

Batya Swift Yasgur, MA, LSW

March 2, 2020

There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.

Multiple Sclerosis

Mental Health Concerns Associated With Mothers of Children With Multiple Sclerosis

By

Brandon May

February 19, 2020

Mothers who have children with MS have a higher prevalence of physical conditions, as well as a higher prevalence of mood and anxiety disorders.

Sleep Disorders

Disability, Quality of Life and Mood May Affect Sleep in Patients With Inflammatory Bowel Disease

February 14, 2020

Sleep quality is associated with mood state, disability, and quality of life among patients with inflammatory bowel disease.

Neurobehavioral Disorders

Psychiatric Disorders Share Common Neural Circuit, Emotion Processing Dysfunction

By

Laurel Ranger

February 13, 2020

The results of the study point to the validity of the Research Domain Criteria initiative and suggest that neuroimaging findings may not be specific to certain psychiatric disorders.

Neurobehavioral Disorders

Deep Brain Stimulation Successfully Treats Refractory OCD Although Targets Vary

By

Yellowlees Douglas, PhD

February 11, 2020

Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.

Two different colored heads facing each other. Concept: Bipolar Disorder

Neurobehavioral Disorders

Comorbid PTSD Raises Risk for Suicidal Ideation in Patients with Bipolar Disorder

By

Emily Pond

February 11, 2020

Compared with patients without PTSD, patients with both bipolar disorder and PTSD were more likely to be women, on disability, have a lower education level, and have a lower annual household income.

Neurobehavioral Disorders

Potential Presence of Foreign Substance Prompts Recall of Alprazolam Lot

By

Brian Park, PharmD

October 28, 2019

Mylan Pharmaceuticals announced the voluntary recall of one lot of alprazolam 0.5mg tablets to the consumer/user level due to the potential presence of a foreign substance.

Uncategorized

Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions

By

Steve Duffy

March 19, 2019

An analysis of data from over 3.5 million patients found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions such as diabetes, hypertension, osteoporosis, depression and anxiety.